Description:N4-Benzoyl-3'-deoxycytidine is a modified nucleoside analog that features a benzoyl group at the N4 position of the cytidine base and lacks the hydroxyl group at the 3' position of the ribose sugar, which is characteristic of deoxycytidine. This compound is of interest in the field of medicinal chemistry and molecular biology due to its potential applications in antiviral and anticancer therapies. The modification enhances its stability and may influence its interaction with nucleic acid targets. N4-benzoyl-3'-deoxycytidine can be utilized in various biochemical assays and research studies aimed at understanding nucleoside function and metabolism. Its structural modifications may also affect its binding affinity and selectivity towards specific enzymes or receptors, making it a valuable tool for investigating nucleoside-related processes. As with many nucleoside analogs, the pharmacological properties, including bioavailability and toxicity, are critical factors that determine its therapeutic potential.
We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.
